• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Roche Holding AG Basel American Depositary Shares (OP:RHHBY)

51.33 UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EDT, Apr 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 51.33
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 51.33
Today's Range 51.33 - 51.33
52wk Range 35.07 - 60.85
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CORRECTING and REPLACING FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus
Today 2:47 EDT
From Genentech
Via Business Wire
News headline image
Could AbbVie Crash Lilly's Weight‑Loss Party? ↗
April 14, 2026
AbbVie is making progress in this market, but it is still far behind the leader. 
Via The Motley Fool

Performance

YTD
-0.2%
-0.2%
1 Month
+6.7%
+6.7%
3 Month
-5.7%
-5.7%
6 Month
+16.5%
+16.5%
1 Year
+32.3%
+32.3%

More News

Read More
News headline image
The Science of Scale: An In-Depth Look at Regeneron Pharmaceuticals (REGN) in 2026
April 13, 2026
Via Finterra
Topics Earnings Economy Intellectual Property
News headline image
C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs)
April 09, 2026
From C4 Therapeutics, Inc.
Via GlobeNewswire
News headline image
Biogen Acquires Apellis Pharmaceuticals in $5.6 Billion Move into Immunology
April 06, 2026
Via MarketMinute
News headline image
The "Liberation Day" Shockwave: US Finalizes 100% Tariffs on Branded Pharmaceutical Imports
April 06, 2026
Via MarketMinute
Topics Economy World Trade
News headline image
The Great Metabolic Land Grab: Why Viking and Structure Have Become Big Pharma’s 'Irresistible' Targets
April 03, 2026
Via MarketMinute
Topics Intellectual Property
News headline image
Trump Issues Landmark Executive Order: 100% Tariffs on Imported Patented Drugs to Force Onshoring
April 03, 2026
Via MarketMinute
Topics Economy Government Lawsuit
News headline image
Regeneron Pharmaceuticals: The Scientific Juggernaut Navigating a High-Stakes Transformation
April 03, 2026
Via Finterra
Topics Economy Intellectual Property World Trade
News headline image
Merck’s Oncology Empire Expands: Keytruda Secures Pivotal European Commission Approval for Recurrent Ovarian Cancer
April 02, 2026
Via MarketMinute
Topics Intellectual Property
News headline image
The Trillion-Dollar Treatment: A Deep Dive into Eli Lilly and Company (LLY)
April 02, 2026
Via Finterra
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Biogen Acquires Apellis Pharmaceuticals in $5.6 Billion Deal After Clinical Success
April 01, 2026
Via MarketMinute
News headline image
United Therapeutics Surges 14% on Groundbreaking Tyvaso Phase 3 Results for IPF
March 31, 2026
Via MarketMinute
News headline image
The $1 Trillion Goliath: Why Eli Lilly’s $6.3B Centessa Bet Defines the Future of Neuroscience
March 31, 2026
Via Finterra
Topics Economy Intellectual Property
News headline image
AstraZeneca (AZN) Shares Rally After Breakthrough Chronic Lung Disease Trial Results
March 27, 2026
Via MarketMinute
Topics Intellectual Property
News headline image
Kodiak Sciences Surges 19% as Phase 3 GLOW2 Trial Delivers Vital Win for Diabetic Retinopathy Treatment
March 26, 2026
Via MarketMinute
News headline image
Sarepta Therapeutics (SRPT) Stock Surges 34.98% on Breakthrough Clinical Data
March 26, 2026
Via MarketMinute
News headline image
Merck & Co. (MRK) 2026 Analysis: Navigating the Keytruda Cliff with Pipeline-Driven Resilience
March 25, 2026
Via Finterra
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Retirees: Collect a High Dividend While Diversifying Your Portfolio With This ETF ↗
March 24, 2026
Via The Motley Fool
Topics ETFs Retirement
News headline image
Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences, Redefining the Future of Cancer Diagnostics
March 23, 2026
Via MarketMinute
Topics Supply Chain
News headline image
The Best Healthcare Stocks to Buy With $50 Right Now ↗
March 18, 2026
Via The Motley Fool
News headline image
Is Eli Lilly's Weight Loss Empire in Trouble? ↗
March 13, 2026
Via The Motley Fool
News headline image
3 ETFs to Avoid as Oil Shock Hits Markets ↗
March 12, 2026
Via MarketBeat
Topics ETFs
News headline image
Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer
March 09, 2026
From Genentech
Via Business Wire
News headline image
2 Underrated Weight Loss Stocks to Buy Now ↗
March 08, 2026
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Roche Holding AG Basel American Depositary Shares publicly traded?
Yes, Roche Holding AG Basel American Depositary Shares is publicly traded.
What exchange does Roche Holding AG Basel American Depositary Shares trade on?
Roche Holding AG Basel American Depositary Shares trades on the OTC Traded
What is the ticker symbol for Roche Holding AG Basel American Depositary Shares?
The ticker symbol for Roche Holding AG Basel American Depositary Shares is RHHBY on the OTC Traded
What is the current price of Roche Holding AG Basel American Depositary Shares?
The current price of Roche Holding AG Basel American Depositary Shares is 51.33
When was Roche Holding AG Basel American Depositary Shares last traded?
The last trade of Roche Holding AG Basel American Depositary Shares was at 04/20/26 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap